Recordkeeping fees per participant
not reported
Not reported on this filing.
Employers › Aclaris Therapeutics
Aclaris Therapeutics 401(k)
- ACRS Nasdaq
- Professional, scientific, and technical services
- Wayne, PA
- EIN 46-0571712
- 1 plan with Schedule H financials
- Plan year 2024
- Aclaris Therapeutics, Inc.
Administrative expenses excluding investment management, per participant · Aclaris Therapeutics Inc 401(k) Plan · plan year 2024
$325.58
Higher than 89% of the 24,371 plans $10 to 50M that report it.
Source
= $35,488 / 109
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251014132904NAL0003028481001, received 2025-10-14
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014132904NAL0003028481001, received 2025-10-14
Percentiles compare this plan with the Schedule H plans $10 to 50M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-10-14.
Cost and contributions
Administrative expenses per participant
$325.58
Higher than 76% of the 25,098 plans $10 to 50M that report it.
Source
= $35,488 / 109
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251014132904NAL0003028481001, received 2025-10-14
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014132904NAL0003028481001, received 2025-10-14
Administrative expenses as a share of assets
0.252%
Higher than 44% of the 25,132 plans $10 to 50M that report it.
Source
= $35,488 / $14,067,523
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251014132904NAL0003028481001, received 2025-10-14
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251014132904NAL0003028481001, received 2025-10-14
Employer contributions per participant
$3,908
Higher than 84% of the 24,050 plans $10 to 50M that report it.
Source
= $426,015 / 109
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251014132904NAL0003028481001, received 2025-10-14
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014132904NAL0003028481001, received 2025-10-14
Employer share of total contributions
26.4%
Higher than 45% of the 24,084 plans $10 to 50M that report it.
Source
= $426,015 / $1,615,132
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251014132904NAL0003028481001, received 2025-10-14
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251014132904NAL0003028481001, received 2025-10-14
Plan terms, as stated in Aclaris Therapeutics, Inc.'s SEC filings
Employer match
“Currently, we match each eligible employee’s contributions up to 4% of total eligible compensation.”
Form 10-K filed 2026-02-26, for the year ended 2025-12-31 · benefits note, 10-K benefits note · source document
Vesting
“Employees are immediately and fully vested in their contributions and our matching contribution.”
Form 10-K filed 2026-02-26, for the year ended 2025-12-31 · benefits note, 10-K benefits note · source document
Terms quoted from the filing for the year ended 2025-12-31. Figures cover plan year 2024. The plan document governs.
Plan features
2E profit-sharing · 2F ERISA 404(c) plan · 2G fully participant-directed · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20251014132904NAL0003028481001, received 2025-10-14
Full record, Aclaris Therapeutics Inc 401(k) Plan
| Field | Value | Source |
|---|---|---|
| Plan sponsor | ACLARIS THERAPEUTICS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Plan name | ACLARIS THERAPEUTICS INC 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Sponsor EIN / plan number | 46-0571712 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Sponsor location | WAYNE, PA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Industry (business code) | 541990, Professional, scientific, and technical services | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Filing received | 2025-10-14 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Participants, beginning of year | 110 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Active participants | 67 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Participants, end of year | 121 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Participants with an account balance | 109 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Total assets, beginning of year | $12,430,834 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Total assets, end of year | $14,067,523 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Net assets, end of year | $14,067,523 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Total income | $3,364,912 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Net income | $1,636,689 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Employer contributions | $426,015 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Participant contributions | $1,166,376 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Other contributions (incl. rollovers) | $22,741 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Total contributions | $1,615,132 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Benefit payments | $1,692,735 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Total expenses (incl. benefit payments) | $1,728,223 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Total administrative expenses | $35,488 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Administrative expenses excluding investment management | $35,488 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Held in common/collective trusts | $67,395 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Held in mutual funds | $13,982,601 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20251014132904NAL0003028481001, received 2025-10-14 |
| Independent auditor | TORRILLO ASSOCIATES, LLC | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20251014132904NAL0003028481001, received 2025-10-14 |
Position = column in the DOL layout for form year 2024. Filing 20251014132904NAL0003028481001, received 2025-10-14.
Service providers paid directly by the plan
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| T. ROWE PRICE RPS, INC.recordkeeper | NONE | 15 Recordkeeping and information management; 21 Trustee (bank, trust company or similar); 25 Trustee (directed); 28 Investment management; 37 Participant loan processing; 38 Participant communication; 49 Other services; 50 Direct payment from the plan; 52 Investment management fees paid indirectly by plan; 57 Redemption fees; 59 Shareholder servicing fees; 62 Float revenue; 63 Distribution (12b-1) fees; 64 Recordkeeping fees; 65 Account maintenance fees | $35,488 | yes |
| PIMCO FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| ALLIANCE GLOBAL FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| PRUDENTIAL JENNISON | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| TIAA-CREF FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| FIDELITY | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| PRINCIPAL FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| JP MORGAN FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
| AB GLOBAL FUNDS | NONE | 28 Investment management; 59 Shareholder servicing fees | $0 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20251014132904NAL0003028481001, received 2025-10-14.
What changed since the 2023 plan year
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $12,430,834 | $14,067,523 | 13.2% |
| Participants with a balance | 104 | 109 | 4.8% |
| Administrative expenses | $32,815 | $35,488 | 8.1% |
| Recordkeeping fees per participant | not reported | not reported | |
| Employer contributions | $707,520 | $426,015 | -39.8% |
Prior filing 20241014091723NAL0025804065001, received 2024-10-14; the plan years are contiguous.
Alerts, claims and corrections
Sponsor name as filed: ACLARIS THERAPEUTICS, INC.; SEC registrant: Aclaris Therapeutics, Inc. (CIK 1557746, matched by EIN).